We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Over budget, overdue and, perhaps, overdesigned.
- Authors
Magnus, Ben
- Abstract
The article reports on the difficulties being faced by the Canada's Multipurpose Applied Physics Lattice Experiment (MAPPLE) reactors dedicated to the production of medical isotopes. The MAPPLE is capable of supplying Canada with medical isotopes used for diagnostics and the destruction of tumours through gamma rays or drugs, yet its operation is still unclear due to some problems in terms of finances. The MAPPLE has been vested with the Atomic Energy of Canada Ltd. (AECL) but the government moved to private it in the late 1980s and bought in 1991 in the form of MDS Health Group Inc. for $165 million. Moreover, renegotiation between MDS Nordion and AECL took place in 2005 and agreed on the transfer of ownership of the Dedicated Isotope Facility to AECL in exchange for $68 million.
- Subjects
CANADA; BIOREACTORS; REACTOR moderators; BIOMEDICAL engineering; ISOTOPES; TUMOR treatment; ATOMIC Energy of Canada Ltd.; MDS Health Group Ltd.; EQUIPMENT &; supplies; THERAPEUTICS
- Publication
Canadian Medical Association Journal (CMAJ), 2008, Vol 178, Issue 7, p813
- Publication type
Article
- DOI
10.1503/cmaj.080320